China's first artificial heart on the market,this artificial heart development success is to rely on advanced technology, our country introduced the Japanese advanced technology, coupled with the domestic excellent senior medical experts together to discuss, constantly improve, constantly do experiments, buy advanced medical equipment, human and material financial support, many medical personnel together to develop a successful.
Academician of the Chinese Academy of Engineering, director of the National Center for Cardiovascular Diseases, Fu Wai Hospital President Hu Shengshou introduced the artificial heart for patients with end-stage or severe heart failure, is the only effective treatment instead of heart transplantation. Its main function is to use bio-mechanical means to partially or completely replace the heart's pumping function to maintain blood circulation throughout the body. In this research, Chongqing-made "Yongrenxin" implantable left ventricular assisted artificial heart clinical trials have been done in Fu Wai Hospital, Wuhan Union Medical College Hospital, Fujian Union Medical College Hospital 17 cases, and achieved complete success.
Previously, only Europe, the United States, Japan and other developed countries have its mature technology, China does not yet have a similar marketed products, most of China's patients due to the extreme lack of heart donor lost the chance of survival. But China attaches great importance to the development of medical science, and is willing to invest money in research, buy Japanese high-tech technology, set up experimental groups, provide equipment, and venues.
In the future, Chongqing Yongren heart plan will be the previous project as an opportunity, in accordance with the gradual realization of the localization of artificial heart, the introduction of more high-quality foreign pharmaceutical medical equipment projects, the establishment of an international cardiovascular disease center of the strategic development of the idea, To create a leading international set of "production, study, research and inspection" as one of the industry chain cluster, to promote the city's strategic emerging medical device industry revitalization and development.
So this artificial heart in a group of aspiring research efforts to develop.